Marsit CJ - Search Results

1

Body mass and smoking are modifiable risk factors for recurrent bladder cancer.

Wyszynski A, Tanyos SA, Rees JR, Marsit CJ, Kelsey KT, Schned AR, Pendleton EM, Celaya MO, Zens MS, Karagas MR, Andrew AS. Wyszynski A, et al. Among authors: marsit cj. Cancer. 2014 Feb 1;120(3):408-14. doi: 10.1002/cncr.28394. Epub 2013 Oct 10. Cancer. 2014. PMID: 24122218 Free PMC article.

2

Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival.

Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT. Marsit CJ, et al. Oncogene. 2004 Jan 29;23(4):1000-4. doi: 10.1038/sj.onc.1207256. Oncogene. 2004. PMID: 14647419

3

Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence.

Marsit CJ, Kim DH, Liu M, Hinds PW, Wiencke JK, Nelson HH, Kelsey KT. Marsit CJ, et al. Int J Cancer. 2005 Mar 20;114(2):219-23. doi: 10.1002/ijc.20714. Int J Cancer. 2005. PMID: 15540210

4

Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.

Marsit CJ, Hasegawa M, Hirao T, Kim DH, Aldape K, Hinds PW, Wiencke JK, Nelson HH, Kelsey KT. Marsit CJ, et al. Cancer Res. 2004 Dec 1;64(23):8702-7. doi: 10.1158/0008-5472.CAN-04-2558. Cancer Res. 2004. PMID: 15574780

5

The race associated allele of Semaphorin 3B (SEMA3B) T415I and its role in lung cancer in African-Americans and Latino-Americans.

Marsit CJ, Wiencke JK, Liu M, Kelsey KT. Marsit CJ, et al. Carcinogenesis. 2005 Aug;26(8):1446-9. doi: 10.1093/carcin/bgi098. Epub 2005 Apr 14. Carcinogenesis. 2005. PMID: 15831529

6

TP53 mutation, allelism and survival in non-small cell lung cancer.

Nelson HH, Wilkojmen M, Marsit CJ, Kelsey KT. Nelson HH, et al. Among authors: marsit cj. Carcinogenesis. 2005 Oct;26(10):1770-3. doi: 10.1093/carcin/bgi125. Epub 2005 May 19. Carcinogenesis. 2005. PMID: 15905205

7

Carcinogen exposure and gene promoter hypermethylation in bladder cancer.

Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A, Nelson HH, Kelsey KT. Marsit CJ, et al. Carcinogenesis. 2006 Jan;27(1):112-6. doi: 10.1093/carcin/bgi172. Epub 2005 Jun 29. Carcinogenesis. 2006. PMID: 15987713

8

Epigenetic silencing of the PRSS3 putative tumor suppressor gene in non-small cell lung cancer.

Marsit CJ, Okpukpara C, Danaee H, Kelsey KT. Marsit CJ, et al. Mol Carcinog. 2005 Oct;44(2):146-50. doi: 10.1002/mc.20125. Mol Carcinog. 2005. PMID: 16013053

9

PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration.

Marsit CJ, Zheng S, Aldape K, Hinds PW, Nelson HH, Wiencke JK, Kelsey KT. Marsit CJ, et al. Hum Pathol. 2005 Jul;36(7):768-76. doi: 10.1016/j.humpath.2005.05.006. Hum Pathol. 2005. PMID: 16084946

10

Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer.

Marsit CJ, Karagas MR, Andrew A, Liu M, Danaee H, Schned AR, Nelson HH, Kelsey KT. Marsit CJ, et al. Cancer Res. 2005 Aug 15;65(16):7081-5. doi: 10.1158/0008-5472.CAN-05-0267. Cancer Res. 2005. PMID: 16103055

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters